RIST4721: Clinical Trials

5 trials of RIST4721, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 terminated, 1 withdrawn. 4 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Terminated 2, Completed 1, Withdrawn 1
Phase 11Completed 1

Follow RIST4721: new trials by email Literature Review of RIST4721 trials Research Report on RIST4721

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate RIST4721 in Familial Mediterranean Fever (FMF)
RIST4721 - Familial Mediterranean Fever
Phase 2WithdrawnAristea Therapeutics, Inc.2022-09-132023-02-13
A Study to Evaluate RIST4721 in Hidradenitis Suppurativa (HS)
RIST4721, Placebo - Hidradenitis Suppurativa
Phase 2TerminatedAristea Therapeutics, Inc.252022-07-182023-06-13
A Phase 2b Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP)
RIST4721, Placebo - Palmoplantar Pustulosis
Phase 2TerminatedAristea Therapeutics, Inc.792022-01-052023-06-29
A Study to Investigate the Effects of RIST4721 on the Inflammatory Response in Healthy Male Subjects Using a Blister Model
RIST4721, Placebo - Inflammatory Response
Phase 1CompletedAristea Therapeutics, Inc.322019-07-252020-06-29
A Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP)
RIST4721, Placebo - Palmoplantar Pustulosis
Phase 2CompletedAristea Therapeutics, Inc.352019-02-132022-04-05

Conditions studied

Psoriasis (2)  ·  Familial Mediterranean Fever (1)  ·  Hidradenitis Suppurativa (1)

Sponsors

Aristea Therapeutics, Inc. (5)

Countries

Canada (3)  ·  Germany (2)  ·  United Kingdom (2)  ·  United States (2)  ·  Czechia (1)  ·  Hungary (1)  ·  Poland (1)

Results publications

PMID 34716902